"Navigating the Modern News Zoo so you don't have to."
Friday, June 6, 2025
Diabetes drug shows benefits for patients with liver disease
The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical trial from China published by The BMJ.
đ Full Story
Chaos erupts at Family Dollar when Black cashier won't refund White woman's shirt #shorts
- Why The Iron Giant Failed - Drew Dietsch
- Rich Banks of Mom & Dad Are EverywhereâAccept It and Adapt - Financial Samurai
- RFK Jrâs plan to ban fluoride supplements will âhurt rural America,â dentists say - Beth Mole
- Banco Cuscatlan Driving Innovations In Latin America - Andrea Murad
- iOS 18 Elevates the iPhone with Unmatched Personalization and Intelligence - Michael A. Medeiros
- Shocking Netflix Horror Anthology Series Elevates Fan Fiction To Disturbing Heights - Robert Scucci
I Like OneUI 8 More Than Android 16!
- Offbeat Mystery Comedy on Prime Video Is A Worthy Proof Of Concept For Multi-Talented A-Lister - Robert Scucci
- What To Know About Toxic Megacolon - Janelle McSwiggin, MSN, RN
- Microsoft Copilot: Ushering a New Era of AI Innovations - Sean George
- A dangerous E. coli strain has emerged; a small mutation may explain its rise - Beth Mole
- Family finds message in bottle on Florida beach thrown into ocean 8 years ago from Hawaii
- White House Tells the GAO to Take a Hike Setting Up a Possible SCOTUS Fight Over Impoundment
